B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Neuropeptide Y

500 PubMed studies analyzed · 11 RCTs · Evidence Score: 42.8

Research Domains

Neuropeptide Y has been studied across 25 research domains including 🔥 Metabolic, 🧘 Stress & Anxiety, 🌤️ Mood & Depression, 🧠 Focus & Attention, 🧬 Hormones. The primary research focus is 🔥 Metabolic with 17% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Neuropeptide Y, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

bdb
2 shared targets
bdb
2 shared targets
bdb
2 shared targets
human
2 shared targets
Peptide
2 shared targets · score 45.1
Propafenone
2 shared targets · score 36.5
Misoprostol
2 shared targets · score 57.3
Nadolol
2 shared targets · score 53.1
Diphenhydramine
2 shared targets · score 31.8
paxilline
2 shared targets · score 39
Loading evidence profile...

This evidence profile for Neuropeptide Y is generated deterministically from 500 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260307-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.